NEUPOGEN - 55513-530-10 - (Filgrastim)

Alphabetical Index


Drug Information of NEUPOGEN

Product NDC: 55513-530
Proprietary Name: NEUPOGEN
Non Proprietary Name: Filgrastim
Active Ingredient(s): 300    ug/mL & nbsp;   Filgrastim
Administration Route(s): INTRAVENOUS; SUBCUTANEOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of NEUPOGEN

Product NDC: 55513-530
Labeler Name: Amgen Inc
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: BLA103353
Marketing Category: BLA
Start Marketing Date: 19970519

Package Information of NEUPOGEN

Package NDC: 55513-530-10
Package Description: 10 VIAL in 1 PACKAGE (55513-530-10) > 1 mL in 1 VIAL (55513-530-01)

NDC Information of NEUPOGEN

NDC Code 55513-530-10
Proprietary Name NEUPOGEN
Package Description 10 VIAL in 1 PACKAGE (55513-530-10) > 1 mL in 1 VIAL (55513-530-01)
Product NDC 55513-530
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Filgrastim
Dosage Form Name INJECTION, SOLUTION
Route Name INTRAVENOUS; SUBCUTANEOUS
Start Marketing Date 19970519
Marketing Category Name BLA
Labeler Name Amgen Inc
Substance Name FILGRASTIM
Strength Number 300
Strength Unit ug/mL
Pharmaceutical Classes Granulocyte Colony-Stimulating Factor [Chemical/Ingredient],Granulocyte-Macrophage Colony-Stimulating Factor [Chemical/Ingredient],Increased Myeloid Cell Production [PE],Leukocyte Growth Factor [EPC]

Complete Information of NEUPOGEN


General Information